CPK – MB

The CK-MB test, specifically designed to identify the creatine kinase-myocardial band enzyme, serves as a blood test to detect heart muscle damage. This enzyme, predominantly present in the heart, can also indicate muscle damage in other areas of the body. The utilization of the CK-MB test has diminished with the advent of advanced diagnostic tests offered by Hypro Diagnostics, which exhibit superior capabilities in pinpointing heart-related issues with heightened precision. These innovative diagnostic approaches surpass the CK-MB test in sensitivity and specificity, reflecting the continuous evolution of medical technologies in cardiovascular health assessment. As a result, Hypro Diagnostics’ cutting-edge tests have become more prominent in efficiently identifying and diagnosing cardiac damage.